GlassScriptPhysician profile
Mark D Foster
NPI 1609876788
$3,389.43
in general payments reported to CMS, 2019-2025
11 companies · $54.07 in 2025
The $54.07 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $812 · 2020: $89.78 · 2021: $89.74 · 2022: $665 · 2023: $1,535 · 2024: $144 · 2025: $54.07.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $924 · Food and Beverage: $809.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $924.19 |
| Food and Beverage | $808.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,412.95 | 2022-2023 | Inbone, Prostep, Prophecy |
| Relievant Medsystems, INC. | $443.09 | 2022-2023 | Intracept |
| Novo Nordisk INC | $343.84 | 2019-2025 | Ozempic |
| Nevro Corp. | $259.84 | 2019-2021 | |
| Globus Medical, INC. | $253.87 | 2019-2024 | Plymouth, Elsa, Modulus |
| Boston Scientific Corporation | $142.97 | 2021-2023 | Wavewriter Alpha Prime 16 |
| Medtronic, INC. | $138.61 | 2022-2025 | Kyphon Express II Kyphopak Tray, Mazor X System, Inceptiv |
| Wright Medical Technology, INC. | $125.18 | 2019 | |
| Medtronic USA, INC. | $124.06 | 2019-2020 | |
| Restor3d, INC. | $110.54 | 2024 | |
| Abbott Laboratories | $34.48 | 2024-2025 | Proclaim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Foster listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.